Navigation Links
into in Medical Technology

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... targeted to the eye from being absorbed into the blood stream. This new delivery system is a ... I.V. drip (i.e. systemically) or by an injection into the eyeball (i.e. intravitreal), both of which ... Because the drug is being administered directly into the eye and not systemically, chemotherapy dosage ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... pipeline by moving at least two additional drugs into development in 2009; one new drug has already moved into development this year ... milestone payment. Isis entered into a license agreement with Alnylam, which provided ...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

... Foundation said today that it has entered into a novel collaborative research agreement with the ... JDRF to speed the translation of basic research into drugs and treatments for type 1 diabetes," said ... of JDRF-funded projects and other discoveries into the program. "Through this collaboration ...

CTMM Becomes One of the World's Largest Public-Private Partnerships in Translational Medical Research

... With today's final approval of a research project into prostate cancer, the Dutch CTMM (Center for ... translational molecular medicine research into innovative new techniques for the diagnosis ... potential to translate research knowledge into clinical practice. CTMM is funded by the Dutch ...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

... in the world, designated to be incorporated into disposable endoscopes or used in various ... CMOS image sensor process and will be integrated into the camera which will be produced in ... class pixel performance, have allowed us to get into this very high margin market which will be ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... move is consistent with Lilly's transformation into a fully integrated pharmaceutical network ... IMC-11F8 is expected to move into Phase III development by the end of 2009; ... or early 2010; IMC-3G3 has recently moved into Phase II development with a study in ovarian ...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

... leftovers safely. Hot foods can go straight into the refrigerator or freezer. They shouldn't be ... a large pot will cool more quickly when divided into smaller, shallower containers. In general, ... known, but others are gradually being integrated into health care practices in the United States. ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... and commercialization agreement entered into in August 2006. "Lupus is a chronic, ... for the development of B-lymphocyte cells into mature plasma B cells. Plasma B cells produce ... GSK In August 2006, HGS and GSK entered into a definitive co-development and ...

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

... action, which allows the antibiotics to penetrate into the bacteria, Fluidosomes(TM)-tobramycin could ... overcome these limitations by packing tobramycin into liposomes, which, by allowing effective penetration of the antibiotic into the bacterial cell, completely changes the ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

... layers of the bladder that has not yet spread into the deeper muscle layer. This form of bladder ... therapy, administered via trans-urethral catheter into the bladder. The first of two Phase III ... administered by trans-urethral catheter directly into the bladder, ...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

... varying doses of niacin. Volunteers were broken into two groups (fed and fasted) and were provided ... if orally over-consumed, turn dissolved tablets into a thick gelatinous mixture making it difficult to draw into a syringe, or produce a mild burning sensation in ...

Alfacell Provides Shareholder Update

... with this function may allow more drug to come into the cells and cause death of the cancer. Another ... also known to be elevated when normal cells turn into mesothelioma cells, and high levels of this gene ... arena. One such experiment we are looking into is whether Onconase can be used as routine tool ...

HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

... has enrolled the first of a planned 235 subjects into a Phase II dose response study investigating an ... in 18 states. "The start of enrollment into this multi-center, randomized trial is an ... two plausible dose frequencies. Enrollment into the trial is preceded by screening and run-in ...

Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients

... -- Body mass index (BMI) should be taken into account when assessing a cancer patient's vitamin ... dietary recommendations for vitamin D do not take into account a patient's BMI," said Carolyn ... patients (BMI <30 kg/m2). BMI should be taken into account when assessing a patient's vitamin D ...

When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research

... estrogens, obtained from pregnant mare's urine, into a woman's body, increased rates of breast cancer ... year period in which a woman's body transitions into menopause. Femmenessence does not introduce any foreign hormones into the system. It simply supports the body's ability ...

Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research

... will support the translation of discoveries into medical products with the potential to prolong ... the translation of Dr. Bell's promising research into important cancer therapeutics," stated David H. ... working together to translate biological research into cutting edge therapies quickly and effectively," ...

VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers

... collecting and fusing multiple vital signs into a validated, actionable health index--helping ... sensor technology and wireless data transmission into a lightweight, comfortable "smart garment" that ... software to fuse data from multiple vital signs into a single index of health status that will provide ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... no echocardiographic exclusion criteria for entry into these trials and there is no monitoring by an ... which in most cases are capable of continuing into 2023 without taking into account any patent term extensions or other ...

WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center

... Surgical System to successfully implant a kidney into a living recipient. This procedure ... is just large enough to introduce the kidney into the recipient's body. It is approximately ... to this surgery, implantation of the donor kidney into the recipient required traditional open surgery. ...

IBM and EU Partners Create a Better Way to Fight AIDS Virus

... but using analytic technologies to take into account treatment response information from ... mathematical prediction models that not only take into account the patient's own history, but tap into the wealth of information that EuResist ...

CuraGen Updates CR011-vcMMAE Data at ASCO

... the maximum tolerated dose and has expanded into a Phase II open-label, multi-center study. The ... session. Thirty-six patients were enrolled into this Phase II open-label, multi-center trial that ... because they expand the activity of CR011 into patients with metastatic breast cancer and open ...

Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials

... in the RECIST Working Group, has incorporated into its RECIST website at http://www.recist.com ... respect to incorporation of the RECIST criteria into Independent Review Charters for regulatory ... of incorporating the new RECIST criteria into medical imaging services to meet immediate demand ...

Novel Vaccine Approach Offers Hope in Fight Against HIV

... used in this animal study might be translated into an HIV vaccine for humans. If the technique leads ... approach taken in the current study was divided into two phases. In the first phase, the research team ... SIV-specific immunoadhesins was engineered into a carrier virus designed to deliver the DNA to ...

Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)

... a syringe and packaging components that take into account some of the challenges many rheumatoid ... a syringe and packaging components that take into account many of the dexterity challenges RA ... We have designed a syringe that that takes into account some of the challenges that come with ...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

... its ability to translate scientific discoveries into practical application," said Ron Kudla, executive ... 33 showed that the compound is absorbed rapidly into the bloodstream, and has a pharmacokinetic ... option to build the most appropriate therapies into treatment programs and fit the needs of ...

Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications

... diagnostic and therapeutic agents across the BBB into the central nervous system ("CNS"). The claims ... with potential partners to advance NeuroTrans(TM) into clinical trials in neurodegenerative diseases." ... therapeutic agents across the blood-brain barrier into the central nervous system; that the allowed ...

Autism Genes Discovered; Help Shape Connections Among Brain Cells

... opens the door to more focused investigations into the causes of autism disorders," said Philip R. ... point for translating biological knowledge into future autism treatments." The hospital's Center ... organization, dedicated to funding research into the causes, prevention, treatments and a cure for ...

University of California Los Angeles Selects Velos eResearch

... "Now our senior leadership will be able to log into the system and be able to access the data they ... processes. "We look forward to moving into a system that will allow us to track studies and ... transmitted by email and fax and manually keyed into the old database. With the new system, the TORI ...

Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin

... associated with translating this approach into an effective and safe vaccine based on live ... to bring this vaccine over the finish line and into widespread use to prevent the devastating ... Center -- findings that were never translated into a vaccine development effort because the task was ...

Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy

... and neutralize chemokine-mediated inflammation into clinical trials. CCL2-LPM has shown a favorable ... significantly decreased the influx of leukocytes into the kidney and resulted in less kidney mesangial ... leukocytes to become activated and to migrate into the kidney where they perpetuate inflammation. ...

Prometheus and Rosetta Genomics Announce License and Collaboration Agreement

... Molecular Diagnostics to Mark Prometheus' Entry into Oncology Market; Rosetta to Receive Milestones ... therapy and are ideally suited to lead our entry into the oncology market, while complementing our ... based on microRNAs. We are delighted to enter into this comprehensive partnership with Prometheus," ...

Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer

... clinical-stage programs through the clinic and into the market." Dr. Rioux said, "I am excited ... year. In November, 2008, Raptor entered into an agreement with the Centre Hospitalier ... clinical-stage programs through the clinic and into the market; that the Company's pipeline could ...

Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack

... (MSCs) can be potentiated by introducing Ad5IGF-1 into the cells while they are being processed outside of the body or ex vivo. Upon reintroduction into the body, these Ad5IGF-1 activated stem cells ... which are processed ex vivo before reintroduction into the body, tend to loose certain capabilities ...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

... vessel support. The first patient was enrolled into the second stage of the ABSORB clinical trial at ... started with balloon angioplasty, which evolved into bare metal stents and then drug eluting metal ... have been eager to enroll their patients into the second stage of the trial," said John ...

Another LNA-based RNA Inhibitor Enters Clinical Trials

... that the fourth LNA-based drug has been brought into the clinic. In the USA several patients with ... the fourth LNA-based drug that has been brought into the clinic in record time either by ourselves or ... to seeing other new LNA-based compounds advance into clinical trials across a range of therapeutic ...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

... and other matters, patients were randomized into multiple titration regimens. After achieving an ... screened patients to stable pain control and into the maintenance period (see above), the ... pathway for approval, our intentions to enter into collaborations or further develop the program are ...

DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology

... San Diego based biomedical company. Integrated into DSM's Trancerta(R) Drug Delivery platform, this ... leveraging its competences in Materials Sciences into Life Sciences applications. MediVas' ... deal we bring in the first biodegradable polymer into DSM's Biomedical portfolio, which significantly ...

Cancer Research 'David' Hopes to Slay 'Cancer Goliath'

... agent resulting from a pre-treated serum injected into a particular large animal. The serum causes the ... antibody which in turn is injected into a special strain of mice that has naturally ... breast cancer. (The injected pre-treated serum into the large animal appears to give the animal ...

Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS

... evidence that the transplanted cells integrated into the nervous system of the host. The rats had a ... cells to be readily accepted by and integrated into a human nervous system, such as in an ALS or a ... therapy is that the cells can integrate into the host to provide function in addition to ...

Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C

... and commercialization agreement entered into in June 2006. (Logo: ... study continued to follow all patients randomized into the trial on an intention-to-treat (ITT) basis ... and commercialization agreement entered into in June 2006. HGS and Novartis will ...
Other Contents
(Date:7/10/2014)... CORAL SPRINGS, Florida , July 1, 2014 ... smart wallets pave way for convenience and improved security: NXT-ID, ... Google Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... ) and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: ... market, is pleased to announce that the second series of ...
(Date:7/10/2014)... 2, 2014 It is a great honor ... appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark ... Dr. Ginsburg, with over 34 years of experience, ... and Good Samaritan Regional Medical Center. Dr. Ginsburg has ... 1980,s and is considered an expert in the implantation ...
(Date:7/10/2014)... According to the new market research report, ... (Optical Prism, Pizeoelectric, Capacitive, and Adhesives), Application (Mobile Devices, ... and Geography - Global Trends & Forecasts to 2014 ... Market is projected to cross $14.35 Billion by 2020, ... to 2020. Browse more than 78 market ...
Breaking Biology News(10 mins):Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2Fingerprint Sensors Market worth $14.35 Billion by 2020 2Fingerprint Sensors Market worth $14.35 Billion by 2020 3
(Date:7/12/2014)... 12, 2014 The ... Vascular Devices Market by Angioplasty Balloon ... (IVUS, OCT), IVC Filter (Retrievable), Endovascular ... analyzes and studies the major market ... U.S. and Canada. , Browse 108 ...
(Date:7/12/2014)... July 12, 2014 The Security Analytics ... 2013 to $3,376.6 million by 2019, at an expected ... 2019. The challenges to counter the increasing number of ... of outdated cyber defense systems in organizations are enormous. ... and remodeling their existing architecture to develop better and ...
(Date:7/12/2014)... 2014 Casinos in Australia ... competition from international and online casinos. Revenue is estimated ... five years through 2014-15. Greater per capita gambling expenditure ... services. Rises in discretionary income levels have also assisted ... non-essential items such as casino gambling services. Revenue is ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 "The second ... it’s uncomfortable and painful to wear shoes," said an inventor ... special sock that prevents this from happening. , He then ... effective way to prevent the second and big toes from ... endurance while wearing shoes. Ergonomic and easy to use, it's ...
(Date:7/12/2014)... Using and carrying around a catheter bag ... Ashland, Va., decided that there needed to be an ... conceive of our design," he said. , They then ... provides an inconspicuous way to use and carry a ... promotes comfort and peace of mind. Producible in design ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
Other TagsOther Tags